Jean Sargent

738 total citations
28 papers, 601 citations indexed

About

Jean Sargent is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Jean Sargent has authored 28 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Jean Sargent's work include Drug Transport and Resistance Mechanisms (8 papers), Acute Myeloid Leukemia Research (7 papers) and HIV/AIDS drug development and treatment (5 papers). Jean Sargent is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Acute Myeloid Leukemia Research (7 papers) and HIV/AIDS drug development and treatment (5 papers). Jean Sargent collaborates with scholars based in United States, United Kingdom and Netherlands. Jean Sargent's co-authors include Christine Williamson, Colin G. Taylor, Gordon Strathdee, Robert Brown, Kim Appleton, James Paul, David Millan, Marc Maliepaard, Rik J. Scheper and Grażyna Lewandowicz and has published in prestigious journals such as Blood, American Journal Of Pathology and British Journal of Cancer.

In The Last Decade

Jean Sargent

27 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Sargent United States 13 348 211 82 60 60 28 601
Karen Fife United States 7 219 0.6× 194 0.9× 108 1.3× 41 0.7× 22 0.4× 12 439
Parul Gupta India 11 260 0.7× 185 0.9× 65 0.8× 18 0.3× 40 0.7× 41 582
Woo‐Young Kim South Korea 14 222 0.6× 217 1.0× 26 0.3× 88 1.5× 67 1.1× 24 534
Z. Günnur Dikmen Türkiye 17 562 1.6× 118 0.6× 70 0.9× 42 0.7× 33 0.6× 40 974
Y Yamane Japan 10 351 1.0× 369 1.7× 47 0.6× 83 1.4× 12 0.2× 23 722
Valérie Le Morvan France 18 389 1.1× 310 1.5× 129 1.6× 36 0.6× 13 0.2× 45 745
E. Rogier France 14 250 0.7× 112 0.5× 87 1.1× 13 0.2× 53 0.9× 23 774
Cynthia S. Lancaster United States 13 226 0.6× 459 2.2× 44 0.5× 206 3.4× 60 1.0× 16 792
Maria A.J. van Eijndhoven Netherlands 7 258 0.7× 356 1.7× 53 0.6× 77 1.3× 26 0.4× 8 520
Seiji Doi Japan 12 365 1.0× 511 2.4× 58 0.7× 78 1.3× 25 0.4× 20 737

Countries citing papers authored by Jean Sargent

Since Specialization
Citations

This map shows the geographic impact of Jean Sargent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Sargent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Sargent more than expected).

Fields of papers citing papers by Jean Sargent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Sargent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Sargent. The network helps show where Jean Sargent may publish in the future.

Co-authorship network of co-authors of Jean Sargent

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Sargent. A scholar is included among the top collaborators of Jean Sargent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Sargent. Jean Sargent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hubeek, Isabelle, Godefridus J. Peters, Jean Sargent, et al.. (2005). Potentiation of in vitro ara‐C cytotoxicity by ribonucleotide reductase inhibitors, cyclin‐dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia. British Journal of Haematology. 131(2). 219–222. 10 indexed citations
2.
Delft, Frederik W. van, Anthony Bellotti, Naina Patel, et al.. (2003). Gene expression profiling in childhood acute leukaemia; a useful classification tool and a first promising insight into drug resistance.. Blood. 102(11). 1 indexed citations
3.
Sargent, Jean. (2003). The Use of the MTT Assay to Study Drug Resistance in Fresh Tumour Samples. Recent results in cancer research. 161. 13–25. 62 indexed citations
4.
5.
Lewandowicz, Grażyna, et al.. (2002). Cellular Glutathione Content, in Vitro Chemoresponse, and the Effect of BSO Modulation in Samples Derived from Patients with Advanced Ovarian Cancer. Gynecologic Oncology. 85(2). 298–304. 33 indexed citations
6.
Coley, Helen M., Jean Sargent, Christine Williamson, et al.. (2002). Assessment of the classical MDR phenotype in epithelial ovarian carcinoma using primary cultures: a feasibility study.. PubMed. 22(1A). 69–74. 5 indexed citations
7.
Sargent, Jean, et al.. (2001). Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562. British Journal of Cancer. 84(7). 959–964. 26 indexed citations
8.
Sargent, Jean, et al.. (2001). Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML. British Journal of Cancer. 84(5). 680–685. 7 indexed citations
9.
Strathdee, Gordon, Kim Appleton, David Millan, et al.. (2001). Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes. American Journal Of Pathology. 158(3). 1121–1127. 170 indexed citations
10.
Sargent, Jean, et al.. (2001). Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia. British Journal of Haematology. 115(2). 257–262. 75 indexed citations
11.
Sargent, Jean, et al.. (1999). Comparison of P-Glycoprotein Expression and Function with in vitro Sensitivity to Anthracyclines in AML. Advances in experimental medicine and biology. 457. 29–33. 7 indexed citations
12.
Sargent, Jean, et al.. (1999). Aphidicolin Markedly Increases the In Vitro Sensitivity to ARA-C of Blast Cells From Patients with AML. Advances in experimental medicine and biology. 457. 567–570. 5 indexed citations
13.
Sargent, Jean, et al.. (1999). Comparison of BCL-2 and Bax Protein Expression with in vitro Sensitivity to ARA-C and 6TG in AML. Advances in experimental medicine and biology. 457. 335–340. 9 indexed citations
14.
Sargent, Jean, et al.. (1999). Evidence for the Involvement of the Glutathione Pathway in Drug Resistance in AML. Advances in experimental medicine and biology. 457. 205–209. 21 indexed citations
15.
Sargent, Jean, et al.. (1998). Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML. Leukemia Research. 22(4). 373–378. 21 indexed citations
16.
Taylor, Colin G., et al.. (1998). The Clinical Relevance of Chemosensitivity Testing in Ovarian Cancer. Cancer Detection and Prevention. 22(4). 305–312. 12 indexed citations
17.
18.
Sargent, Jean, Helen M. Coley, Christine Williamson, & Colman Taylor. (1998). Evidence of ABC transporters in fresh tumor cells from patients with ovarian cancer.. PubMed. 36(2). 64–6. 1 indexed citations
19.
Sargent, Jean, et al.. (1996). An in vitro study of blast cell metabolism in acute myeloid leukaemia using the MTT assay. Leukemia Research. 20(5). 407–413. 4 indexed citations
20.
HILL, N. C. W., et al.. (1988). Effect of low dose heparin on blood loss at caesarean section. BMJ. 296(6635). 1505–1506. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Fife Breakdown of academic impact, for papers by Parul Gupta Breakdown of academic impact, for papers by Woo‐Young Kim Breakdown of academic impact, for papers by Z. Günnur Dikmen Breakdown of academic impact, for papers by Y Yamane Breakdown of academic impact, for papers by Valérie Le Morvan Breakdown of academic impact, for papers by E. Rogier Breakdown of academic impact, for papers by Cynthia S. Lancaster Breakdown of academic impact, for papers by Maria A.J. van Eijndhoven Breakdown of academic impact, for papers by Seiji Doi
Rankless by CCL
2026